[{"data":1,"prerenderedAt":24},["ShallowReactive",2],{"$fOKnnUJhOESWT-g8NpDLgLOCAp__OZZOlcisY8_5uzGE":3},{"card":4,"examId":6,"chapterTitle":21,"prev":22,"next":23},{"id":5,"examId":6,"prompt":7,"answer":8,"choices":9,"questionType":12,"explanation":13,"explanationDetail":14,"mistakeHint":15,"lectureRef":15,"storyRef":15,"chapterSlug":16,"sectionCode":17,"sectionTitle":18,"clusterSlug":19,"term":15,"sequenceOrder":15,"regionWeight":15,"revisionMark":15,"isActive":20},"ch4-078","touhan","ジヒドロコデインは濫用等のおそれのある医薬品として厚生労働大臣が指定する成分に含まれる。",0,[10,11],"正しい","誤り","ox","ジヒドロコデインは濫用等のおそれのある指定成分6種の一つです（平成26年厚生労働省告示第252号）。","コデインとジヒドロコデインはどちらも指定成分です。咳止め薬などに含まれている場合があるため、販売時の確認が重要です。",null,"chapter-4","4-II-2","リスク区分に応じた販売方法・特定販売","rannyou-iyakuhin",true,"第4章 薬事関係法規・制度","ch4-077","ch4-079",1784619074377]